← Evidence map

ReviewHuman vaccines & immunotherapeutics2022

Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.

Qiliang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36170662